Cervical cancer, the fourth most common cancer among women globally, remains a critical public health challenge, with a significant burden in India and other developing nations. In a major preventive ...

Intervacc AB (publ) is first in the world to show that piglets were protected against the virulent and severe disease-causing S. suis Sequence Types 1 and 16 (serotype 2 and 9, respectively), by vacci ...

The use of the nucleic acid platform for antigen delivery has expanded rapidly in the past decade, highlighted by the development and deployment of several nucleic acid vaccines for SARS-CoV-2 and the ...

In a proof-of-concept study, researchers tested a novel approach to mitigate deadly bat-borne viruses from jumping into ...

In 2021, a global tuberculosis vaccine research and development roadmap proposed a series of actions to accelerate the development of new, effective, and affordable vaccines that are urgently needed ...

Researchers boosted levels of a heart-healing hormone in mice and pigs with a single injection of a new, experimental form of self-amplifying RNA that prolonged hormone synthesis for many weeks.

The next generation RNA therapeutics market presents significant growth opportunities, driven by the development of over 100 RNA therapies and vaccines, advancing research, and robust investment ...

Rates of newborn vitamin K shot refusal remain low but appear to be increasing, raising concerns about misinformation and the need for stronger prenatal counseling.

Pune: The PMC on Monday launched a dedicated vaccination drive against Human Papillomavirus (HPV) to protect young girls from cervical cancer. On the .

Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "M-M-R II Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The ...

Proper pullet vaccination underpins the protection of layers and broiler breeders during the rearing phase. When done correctly, it stabilises egg ...

Invivyd (NASDAQ:IVVD) executives used the company’s fourth-quarter 2025 earnings call to outline progress in its COVID-19 monoclonal antibody pipeline, provide an update on commercialization of ...